SAGE Sage Therapeutics Inc: Narxning prognoz qilingan daromadga nisbati

Sage Therapeutics (SAGE) kompaniyasining rasmiy ramzlari

Sage Therapeutics, Inc. (SAGE) dori ishlab chiqarishda shartnomaviy ishlab chiqaruvchilarga tayanadi, shu bilan birga qat'iy ichki sifat nazoratini saqlaydi. Emitentning forward P/S ko'rsatkichi biznesning baholanish tendentsiyasini aks ettiradi va joriy daraja 7.80 atrofida shakllangan. Avvalroq nevrologiya ekspertlarining sodiqligi ilmiy progressni rag'batlantirgan bo'lsa-da, kompaniya hozirda muvaffaqiyatsiz sinovlardan so'ng shtat raqamini qisqartirmoqda va asosiy olimlarni saqlab qolish uchun aksiyalar opsiyonlaridan foydalanmoqda.

Sage Therapeutics - SAGE Forvard P/S multiplikatori (davr: 04.07.2022 - 16.08.2025)

SAGE (Sage Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning fundamental tahlili:Sage Therapeutics (SAGE)
sagerx.com tovar namunasi

Investorlar Sage Therapeutics, Inc. (SAGE) kompaniyasini depressiyaga qarshi dori vositasining sekin joriy etilishi va Altsgeymer kasalligi tadqiqotlari bilan bog'liq xatarlar prizmasi orqali baholamoqda, bu esa daromadning beqarorligiga olib kelmoqda. GURU.Markets platformasidagi kelajakdagi daromad koeffitsienti joriy bozor kapitalizatsiyasini kutilayotgan yillik savdo aylanmasi bilan solishtiradi, bu esa kompaniyaning cheklangan naqd pul zaxiralari sharoitida bozor kelajakdagi o'sish uchun haddan tashqari ko'p to'layotganini aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|ANVS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grace Therapeutics Inc|AIFF: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Klotho Neurosciences Inc (KLTO)|Narxning prognoz qilingan daromadga nisbati neurosense-tx.com|Bozor kapitallashuvining kelajakdagi daromadga nisbati Reviva Pharmaceuticals Holdings Inc. RVPH|Narxning prognoz qilingan daromadga nisbati MetaVia Inc. (MTVA)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati NeurAxis Inc|Forvard P/S multiplikatori HSDT (heliusmedical.com)|Sotuvga nisbatan forvard narx PASG|NEUP: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Minerva Neurosciences Inc|Athira Pharma (ATHA) - Narxning prognoz qilingan daromadga nisbati|Addex Therapeutics, Ltd. - Sotuvga nisbatan forvard narx|ALZN (Alzamend Neuro) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati cyclerion.com CYCN|Forvard P/S multiplikatori PTIX|KTTA - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics Inc (ATXI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|BCLI - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati caratherapeutics.com|CHRO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Eliem Therapeutics (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Longboard|Forvard P/S multiplikatori MRNS|Kapitalizatsiyaning kutilayotgan sotuvga nisbati nkgenbiotech.com|Forvard P/S multiplikatori NRBO (neurobopharma.com)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori